GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » EBIT

Sipai Health Technology Co (HKSE:00314) EBIT : HK$-382 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sipai Health Technology Co EBIT?

Sipai Health Technology Co's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was HK$-79 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-382 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sipai Health Technology Co's annualized ROC % for the quarter that ended in Jun. 2024 was -21.81%. Sipai Health Technology Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -183.23%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Sipai Health Technology Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -12.75%.


Sipai Health Technology Co EBIT Historical Data

The historical data trend for Sipai Health Technology Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sipai Health Technology Co EBIT Chart

Sipai Health Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial -1,229.68 -4,584.39 -1,523.65 -264.89 -381.77

Sipai Health Technology Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,141.19 -92.83 -172.06 -79.24 -303.18

Competitive Comparison of Sipai Health Technology Co's EBIT

For the Medical Distribution subindustry, Sipai Health Technology Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sipai Health Technology Co's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sipai Health Technology Co's EV-to-EBIT falls into.


';

Sipai Health Technology Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-382 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sipai Health Technology Co  (HKSE:00314) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sipai Health Technology Co's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=-184.706 * ( 1 - 0.68% )/( (824.266 + 857.759)/ 2 )
=-183.4499992/841.0125
=-21.81 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3079.031 - 1019.203 - ( 1235.562 - max(0, 1249.023 - 2671.526+1235.562))
=824.266

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3139.897 - 1253.971 - ( 1028.167 - max(0, 1470.368 - 2676.02+1028.167))
=857.759

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Sipai Health Technology Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-158.484/( ( (88.712 + max(-98.005, 0)) + (84.275 + max(-170.143, 0)) )/ 2 )
=-158.484/( ( 88.712 + 84.275 )/ 2 )
=-158.484/86.4935
=-183.23 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(360.429 + 269.133 + 490.592) - (1019.203 + 0 + 198.956)
=-98.005

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(391.404 + 350.417 + 533.061) - (1253.971 + 0 + 191.054)
=-170.143

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Sipai Health Technology Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=-382.422/2999.517
=-12.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sipai Health Technology Co EBIT Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Sipai Health Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
Executives
Impresa Management Llc
Eight Roads Holdings L.p. 2201 Interest of corporation controlled by you
Eight Roads Management Limited 2201 Interest of corporation controlled by you
Crow Lane Limited 2201 Interest of corporation controlled by you
Cliff Trail Llc 2201 Interest of corporation controlled by you
Impresa Fund Iii Limited Partnership
Pandanus Partners L.p.
Fil Limited
Fmr Llc
Johnson Abigail P.
Johnson Iv Edward C.
Pandanus Associates Inc.
Eight Roads Shareholdings Limited
Chang Jimmy Ching-hsin 2201 Interest of corporation controlled by you
Purple Panther 2201 Interest of corporation controlled by you

Sipai Health Technology Co Headlines

No Headlines